Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Genelux Corporation
Genelux Corporation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Imunon
AbbVie
Merck Sharp & Dohme LLC
Mural Oncology, Inc
AbbVie
pharmaand GmbH
Corcept Therapeutics
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Hoffmann-La Roche
ImmunoGen, Inc.
Advenchen Laboratories, LLC
Mersana Therapeutics
pharmaand GmbH
pharmaand GmbH
Pfizer
Hoffmann-La Roche
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
OncXerna Theraputics, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Novartis
Novartis
ImmunoGen, Inc.
Janssen Research & Development, LLC
Amgen
Genentech, Inc.
Amgen
Amgen
MEI Pharma, Inc.
INSYS Therapeutics Inc
Oasmia Pharmaceutical AB
Eli Lilly and Company
Eli Lilly and Company